GB001 (Zhejiang Echon Biopharm)

GB001 is a recombinant peptide therapeutic developed by Zhejiang Echon Biopharm Limited for the treatment of recurrent aphthous ulcers (canker sores). Formulated as a topical oral spray, it is intended for local application to oral mucosal lesions to promote healing and alleviate symptoms. The drug has been evaluated in a multicenter, randomized, double-blind, placebo-controlled Phase IIa clinical trial in China to assess its efficacy, safety, and pharmacokinetics in adults with mild recurrent aphthous ulcers. As a biologic therapeutic, GB001 represents a novel approach to managing oral ulcers, although specific details regarding its peptide sequence and molecular target remain proprietary.

Other names

GB001 recombinant peptide sprayGB-001 recombinant peptide sprayGB 001 recombinant peptide spray